MCFT vs RARE · P/E 35, rev $79.5M vs rev $350.0M
MCBC Holdings Inc (MCFT) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
MCBC Holdings Inc (MCFT) is a recreational vehicles company listed on NASDAQ.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported MCFT revenue for 2025-06-30 was $79.5M. Net income was $5.7M. Revenue was up 4.7% from 2025-03-30 to 2025-06-30. MCFT currently screens at market cap $560.6M and trailing P/E 34.5.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
MCFT currently screens at market cap $560.6M and trailing P/E 34.5. RARE currently screens at market cap $2.79B.
Not investment advice. Open the MCFT and RARE stock pages for the full models.
Not investment advice.